e-ISSN: 2717-7149
  • Home
  • About The Journal
  • Editorial Board
  • Instructions for Authors
  • Contact
Current Issue
Ahead Of Print
Archive
Search
Most Popular
Download Articles Read Articles
Retina Arter Tıkanıklıkları ve Tedavisi...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Bilateral Optic Disc Drusen
Vascular Endothelial Growth Factor and Anti VEGF Agents...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Retina Arter Tıkanıklıkları ve Tedavisi...
Morning Glory Syndrome Associated with Retinochoroidal Coloboma...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Bilateral Optic Disc Drusen
PureSee Kesintisiz Yüksek Kalitede Görüş
Retina-Vitreous 2007 , Vol 15 , Num 2
Turkish Abstract Abstract Article PDF Similar Articles Mail to Author
Combined Central Retinal Vein and Branch Retinal Artery Occlusion in a Patient with Coexisting Heterozygous Factor V and Prothrombin 20210A Mutations
Mehmet Numan ALP1, Fatih Mehmet TÜRKÇÜ2, Muharrem TOLA3, Gülcan KURAL4
1Numune Eğitim ve Araştırma Hastanesi, 1. Göz Kliniği, Ankara, Uzm. Dr.
2Numune Eğitim ve Araştırma Hastanesi, 1. Göz Kliniği Asistanı, Ankara, Dr.
3Türkiye Yüksek İhtisas Hastanesi, Radyoloji Kliniği, Ankara, Doç. Dr.
4Numune Eğitim ve Araştırma Hastanesi, 1. Göz Kliniği Şefi, Ankara, Uzm. Dr.
Although, a relation between retinal vein occlusion and each of factor V Leiden and prothrombin G20210A mutations has not been clearly defined, it is known that the risk for ocular venous occlusion in patients with coexisting mutations was increased. It is also reported that acquired or inherited thrombophilia may play a role in the etiology of retinal artery occlusion particularly in young adults. We reported herein the first case in the literature of which a combined central retinal vein and branch retinal artery occlusion in a patient with coexisting factor V and prothrombin 20210A mutations was presented as an occasion for emphasizing the importance of screening for thrombophilia factors in patients with combined retinal vascular occlusions and early administration of the antithrombotic therapy in affected patients for achieving good visual outcomes. Keywords : Factor V, low molecular weight heparin, mutation, prothrombin 20210A, retinal artery occlusion, retinal vein occlusion
PureSee Kesintisiz Yüksek Kalitede Görüş
Home
About The Journal
Editorial Board
Instructions for Authors
Contact